Nuburu enters defense JV with Maddox to develop mobile additive manufacturing platform

Nuburu, Inc.

Nuburu funds up to $4M in Phase I for Maddox's development of a containerized additive manufacturing platform for drone components.
Phase II forms NewCo (60% owned by Nuburu, 40% by Maddox) as exclusive commercial vehicle for the product.
Nuburu gets a governance allocation of 10% of Development Funds; NewCo's distributable profits repay Nuburu first.
Steering Committee with 2 reps each oversees Phase I; deadlock resolved per agreement procedures.
Initial 5-year term with auto-renewal; NewCo to act as prime contractor for US and EU/NATO contracts as permissible.

item 1.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Nuburu, Inc. entered into Contractual Joint Venture Agreement with Maddox Defense Incorporated (effective 2026-02-26).

Action: entry
Agreement: collaboration
Counterparty: Maddox Defense Incorporated
Effective: 2026-02-26

Exact text from the filing

On February 26, 2026, Nuburu, Inc. and Nuburu Defense, LLC (jointly, the “Company”) entered into a Contractual Joint Venture Agreement (the “Agreement”), with Maddox Defense Incorporated (“Maddox”), pursuant to which the Company and Maddox have established a contractual joint venture for the development of a modular, containerized, mobile additive manufacturing platform capable of producing drone components, pods, mission-critical structural parts and related components for defense and security applications (the “Program” or the “Product”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Nuburu, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-083154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.